Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1° mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2009, Pages 417-421

  Coelho, J C ^a   Tucker, R ^a   Mattoon, J ^a   Roberts, G ^a   Waiting, D K ^a   Mealey, K L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; KETOCONAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DOG; DRUG EXCRETION; GENE MUTATION; ISOTOPE LABELING; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BILE; DOGS; DRUG INTERACTIONS; FEMALE; GALLBLADDER; GAMMA CAMERAS; KETOCONAZOLE; MALE; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; TECHNETIUM TC 99M SESTAMIBI;

CANIS FAMILIARIS;

EID: 70349126735     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01068.x     Document Type: Article

References (18)

1. Abdel-Dayem, H.M. (1997) The role of nuclear medicine in primary bone and soft tissue tumors. Seminars in Nuclear Medicine, 27, 355 363.
2. Barbarics, E., Kronauge, J.F., Costello, C.E., Janoki, G.A., Holman, B.L., Davison, A. Jones, A.G. (1994) In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+. Nuclear Medicine and Biology, 21, 583 591.
3. Cornwell, M.M. (1991) Molecular biology of P-glycoprotein. Cancer Treatment and Research, 57, 37 56.
4. Fukumoto, M. (2004) Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin. Annals of Nuclear Medicine, 18, 79 95.
5. Ginn, P.E. (1996) Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Veterinary Pathology, 33, 533 541.
6. Kabasakal, L., Halac, M., Nisli, C., Oguz, O., Onsel, C., Civi, G. Uslu, I. (2000) The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi. Clinical Nuclear Medicine, 25, 20 23.
7. McDevitt, C.A. Callaghan, R. (2007) How can we best use structural information on P-glycoprotein to design inhibitors? Pharmacology and Therapeutics, 113, 429 441.
8. Mealey, K.L., Bentjen, S.A., Gay, J.M. Cantor, G.H. (2001) Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics, 11, 727 733.
9. Mealey, K.L., Northrup, N.C. Bentjen, S.A. (2003) Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. Journal of the American Veterinary Medical Association, 223, 1453 1455, 1434.
10. Mealey, K.L., Fidel, J., Gay, J.M., Impellizeri, J.A., Clifford, C.A. Bergman, P.J. (2008a) ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine. Journal of Veterinary Internal Medicine, 22, 996 1000.
11. Mealey, K.L., Greene, S., Bagley, R., Gay, J., Tucker, R., Gavin, P., Schmidt, K. Nelson, F. (2008b) P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine p-glycoprotein knockout model. Drug Metabolism and Disposition, 36, 1073 1079.
12. Neff, M.W., Robertson, K.R., Wong, A.K., Safra, N., Broman, K.W., Slatkin, M., Mealey, K.L. Pedersen, N.C. (2004) Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proceedings of the National Academy of Sciences of the United States of America, 101, 11725 11730.
13. Nobili, S., Landini, I., Giglioni, B. Mini, E. (2006) Pharmacological strategies for overcoming multidrug resistance. Current Drug Targets, 7, 861 879.
14. Sartor, L.L., Bentjen, S.A., Trepanier, L. Mealey, K.L. (2004) Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. Journal of Veterinary Internal Medicine, 18, 117 118.
15. Schinkel, A.H. Jonker, J.W. (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews, 55, 3 29.
16. Slart, R.H., Bax, J.J., van Veldhuisen, D.J., van der Wall, E.E., Dierckx, R.A. Jager, P.L. (2006) Imaging techniques in nuclear cardiology for the assessment of myocardial viability. The International Journal of Cardiovascular Imaging, 22, 63 80.
17. Song, S., Suzuki, H., Kawai, R. Sugiyama, Y. (1999) Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug Metabolism and Disposition, 27, 689 694.
18. Watanabe, T., Suzuki, H., Sawada, Y., Naito, M., Tsuruo, T., Inaba, M., Hanano, M. Sugiyama, Y. (1995) Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. Journal of Hepatology, 23, 440 448.